Whole-Genome Sequencing Identifies In Vivo Acquisition of a blaCTX-M-27-Carrying IncFII Transmissible Plasmid as the Cause of Ceftriaxone Treatment Failure for an Invasive Salmonella enterica Serovar Typhimurium Infection.

PMID: 276710662016United States

Key Findings

The study identified the in vivo acquisition of a blaCTX-M-27-carrying IncFII plasmid in a Salmonella enterica serovar Typhimurium isolate, leading to ceftriaxone resistance.

View on PubMed

1gene entry

0mutation entries

AMR Genes

Gene Name	Alleles	Encodes	Confers Resistance To	Organisms	Database	Validation Status
blaCTX-M	1	beta-lactamase	Ceftriaxone	Salmonella enterica serovar Typhimurium Escherichia coli	Reslit	-

Browse Papers

Whole-Genome Sequencing Identifies In Vivo Acquisition of a blaCTX-M-27-Carrying IncFII Transmissible Plasmid as the Cause of Ceftriaxone Treatment Failure for an Invasive Salmonella enterica Serovar Typhimurium Infection.

AMR Genes